Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000584058 | SCV000686888 | likely benign | Hereditary cancer-predisposing syndrome | 2016-11-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV004562570 | SCV000768403 | likely benign | Familial adenomatous polyposis 1 | 2023-12-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000584058 | SCV001176003 | likely benign | Hereditary cancer-predisposing syndrome | 2018-12-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV004001285 | SCV004839667 | likely benign | Classic or attenuated familial adenomatous polyposis | 2023-12-13 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004562570 | SCV004931642 | benign | Familial adenomatous polyposis 1 | 2024-03-11 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |